A novel stability indicating reversed phase high performance liquid chromatography (RP-HPLC) method was developed and validated for the simultaneous determination of hydrochlorothiazide (HCT), amiloride hydrochloride (AMD) and timolol maleate (TIM) in a tablet dosage form. The chromatographic separation was performed on a Shimadzu Nexera LC-30AD system using Inertsil ® C8-3 column (4.6 mm x 150 mm, 5µ) and isocratic elution of methanol and a solution containing ion-pairing agent (1.5 g of 1-hexane sulfonic acid sodium salt, 30 mL glacial acetic acid,1 mL triethylamine dissolved in 1800 mL purified water and pH adjusted to 2.4 ± 0.05 with phosphoric acid then volume completed to 2000 mL by purified water) (40: 60, v/v) at a flow rate of 1.0 mL/min. UV detection was performed at 286 nm. Total run time was 7 min within which main compounds and degradants were separated. Stability indicating capability was established by forced degradation experiments. The method was validated for linearity, repeatability, trueness, specificity and robustness. Limit of detection (LOD) and limit of quantification (LOQ) were also established.
Introduction
Hydrochlorothiazide (HCT) is a moderately potent diuretic and is chemically described as 6-chloro-3,4-dihydro-2H-1,2,4benzothiadiazine-7-sulfonamide 1,1-dioxide. Its empirical formula is C 7 H 8 ClN 3 O 4 S 2 and its structural formula is depicted (Fig. 1a. ) Amiloride hydrochloride (AMD) is a weak diuretic and is described as potassium sparing since it increases the excretion of sodium and reduces the excretion of potassium. AMD is chemically described as 3,5-diamino-N-carbamimidoyl- Chromatography (2016) Vol. 3 No. 1 pp. 23-32 24 6-chloropyrazine-2-carboxamide hydrochloride dehydrate. Its empirical formula is C 6 H 8 ClN 7 O.HCl.2H 2 O and its structural formula is shown in (Fig.1b) .Timolol maleate (TIM) is a noncardioselective β-blocker used in the management of several cardio-vascular disorders. Its chemical name is (S)-1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-2-propanol (Z)-2-butenedioate (1:1) salt. Its empirical formula is C 13 H 24 N 4 O 3 S.C 4 H 4 O 4 and its structural formula is shown in (Fig. 1c) (www.rxlist.com, 2015) . Combination of HCT and TIM is used for the management of hypertension and AMD is useful for the prevention of hypokalemia induced by hydrochlorothiazide especially during prolonged treatment (Sweetman, 2009 ). Separation of pharmaceutical preparations containing a combination of these three drugs is often a complex analytical problem since they have similar chromatographic behavior and UV spectra (Moffat, 1986) . To the best of my knowledge, no HPLC method has been reported yet for simultaneous estimation of ternary mixture of hydrochlorothiazide, amiloride hydrochloride and timolol maleate in pharmaceutical dosage forms. There are only few published reports on the simultaneous separation of this combination such as chemometric methods (Ferraro et al., 2004) , high-performance flow injection system (Bigley et al., 1986) , derivative spectrophotometry and derivative ratio spectrophotometry (Abdel-Hay et al., 2008) , the reported methods are somewhat complicated and can't be considered as stability indicating methods. In this study the first RP-HPLC method for the simultaneous determination of the mixture of HCT, AMD and TIM in tablet dosage form is reported. The method was able to separate these compounds as well as other unknown degradation products within a run time of 7 minutes. The study was performed in accordance with established ICH guidelines (USA: ICH, 2003 ) and successfully applied for simultaneous determination of hydrochlorothiazide, amiloride hydrochloride and timolol maleate. 
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Experimental
Chemicals and materials
Ion-pairing solution preparation
1.5 g of 1-hexane sulfonic acid sodium salt, 30 mL of glacial acetic acid and 1 mL of triethylamine were added to 1800 mL purified water, adjusted to a pH of 2.4 by phosphoric acid then completed to 2000 mL with purified water. The solution was found stable with respect to pH and visual clarity for 3days.
Mobile phase: a filtered and degassed mixture of methanol and ion-pairing solution by (40: 60, v/v) ratio.
Chromatographic system
The analysis was performed on a Shimadzu Nexera LC-30AD system (Shimadzu Corporation, Kyoto, Japan) consisting of LC-30 AD-LPGE pump, SPD-20A UV detector, DGU-20A5 Degasser. A Shimadzu SIL-30AC autosampler was used to inject 10 µL of the samples on an Inertsil ® C8-3 column (4.6 mm x 150 mm, 5µ), GL Sciences, Japan), which was kept at 40°C. The detection was carried out at 286 nm. Mobile phase was filtered through a 0.22 µm membrane filter (Chromatech, UK or equivalent), then degassed ultrasonically for 5 min and delivered at a flow rate of 1.0 mL/min.
Solutions preparation
Standard solution:
Standard solution was prepared by dissolving standard substances in a small portion of methanol, sonicated for 5 min and diluted up to the mark with mobile phase to obtain a solution containing, 25µg/ml of HCT, 2.5 μg/ml of AMD and 10 µg/ml of TIM.
Formulation sample solution:
Twenty tablets were grinded to fine powder, an accurately weighed portion of the powder equivalent to 25 mg of HCT, 2.5 mg of AMD, and 10 mg of TIM per one tablet were taken in 100 ml volumetric flask. About 20 ml of methanol was added to this flask and the flask was sonicated in an ultrasonic bath. The volume was completed to the mark with methanol, then 10 mL of this solution was diluted to 100 using mobile phase then filtered through a 0.22 μ syringe filter.
Results and Discussion
Method development and optimization
The main target of the chromatographic method was achieving a method for simultaneous assay for HCT, AMD and TIM. The combined standard solution (25µg/ml of HCT, 2.5µg/ml of AMD and 10 µg/ml of TIM) was injected. For method optimization different chromatographic conditions were experimented to achieve better efficiency of the system and after many trials the method was applied using an Inertsil ® C8-3 column (4.6 mm x 150 mm, 5µ) as a stationary phase and mobile phase consisting of methanol and ion-pairing solution by ratio (40: 60) giving good separation of HCT, AMD and TIM peaks, acceptable retention time, peak shape, plate's count and good resolution.
Chromatogram obtained for HCT, AMD and TIM from final HPLC conditions is shown in (Fig. 2) .
Fig. 2.
Chromatogram of hydrochlorothiazide (HCT, 25µg/ml), amiloride hydrochloride (AMD, 2.5 μg/ml), and timolol maleate (TIM, 10 µg/ml) by proposed method.
Method validation
System suitability
System suitability was performed from six replicate injections of mixed standard solution. The following requirements were fulfilled, % RSD of peak responses due to HCT, AMD and TIM for the six replicate injections must be less than or equal to 2.0 %, tailing must be less than 2.0 %, resolution must be less than 2.5 and theoretical plates count must be more than 20000. System suitability parameters were calculated and are presented in (Table 1) . 
Linearity
Linearity of an analytical procedure is its ability to obtain results which are directly proportional to
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27 concentration of the analyte in the sample. It was studied by preparing standard solutions at different concentration levels ranging from 80 % to 120 % of test concentration (20-30 µg/ml for HCT, 2-3 µg/ml for AMD and 8-12 µg/ml for TIM). Peak responses of the components on Y-axis and the corresponding concentrations on X-axis were drawn. A linear regression curve was obtained and the correlation coefficient (r) was estimated ( Figures: 3a-c) .
Fig. 3a.
HCT linearity curve. Fig. 3b . AMD linearity curve. Fig. 3c . TIM linearity curve. 28 the analyte (n=6) using the proposed method. The low value of standard deviation showed that the method was precise. The results obtained were presented in (Table2).
Precision
Trueness
The trueness of the developed method was determined by the percentage recovery of each concentration with respect to real values. The trueness of the assay method was evaluated in triplicate at three concentration levels 90%, 100% and 110% of the label claim. Amount of drug recovered was quantified and % recovery was calculated from amount found and actual amount added. The results of the trueness study are reported in (Table 3 ). For the three drugs, at the different concentration levels, the recovery values meet the acceptance criteria of 100 ±2%. In addition, these results provide the working range for the method. 
Specificity
Specificity is the ability of the method to measure the analyte response in the presence of its potential impurities (Geneva, Switzerland: ICH, 2005) . Forced degradation studies were performed to demonstrate selectivity and stability indicating capability of the proposed method. The standard was exposed to various degradation conditions -acidic (1M HCl, 60°C, 30 min), alkaline (1M NaOH, 60°C, 30 min), oxidizing (3% H 2 O 2 , 60°C, 30 min). HCT, AMD, and TIM were found to be sensitive to oxidative degradation ( Figures: 4a-d) . The figures show that there is no interference at the retention time of HCT, AMD and TIM due to placebo or degradation products, indicating that the method is specific and stability indicating. 
Robustness
To prove the reliability of the analytical method during normal usage, some small but deliberate changes were made in analytical method (e.g., flow rate and column temperature). Changes in chromatographic parameters (i.e., theoretical plates and tailing factor) were evaluated for the studies. In all the deliberately varied chromatographic conditions, the chromatogram for system suitability solution showed satisfactory resolution (RSD < 2%) with no significant changes in chromatographic parameters (Table 4) . 
Limit of detection (LOD) and Limit of quantitation (LOQ)
Sensitivity of the method was proved by establishing the limits of detection (LOD) and quantitation (LOQ) for HCT, AMD and TIM in pure and in dosage forms. The LOD and LOQ were determined by visual inspection using signal to noise approach, by injecting a series of dilute solutions with known concentrations. The concentration (in μg/mL) with signal to noise ratio of at least 3 was taken as LOD and concentration with signal to noise ratio of at least 10 was taken as LOQ. The limit of detection of HCT, AMD and TIM was 20, 240 and 90 ng/mL, respectively. The limit of quantification was 80, 750 and 30 ng/ mL, respectively.
Stability of standard solution, sample solution and mobile phase
The solution stability method was carried out by leaving the both the solutions of sample and standard in tightly capped volumetric flasks at room temperature for 3 days. The same sample solutions were analyzed after 3 days. The mobile phase stability was also carried out by assaying the freshly prepared sample solutions against freshly prepared standard solution for 3 days. Mobile phase was kept constant during the study period. There is no significant change in the solutions up to a period of 3 days; all the drugs had enough stability up to 3 days after preparation.
Conclusion
A novel RP-HPLC method was successfully developed and validated for simultaneous determination of HCT, AMD and TIM in tablets dosage form. All the drugs were found to be well resolved in a run time of 7 min. No interference was found with the degradants and excipients. Validation results have proved that the method is selective, precise, accurate, robust and stability indicating which can be successfully applied for the routine analysis as well as for stability studies.
